Increases in BMI1 were also reported in epithelial malignancies, including non-small cell lung cancer (NSCLC) [14], colon cancer [15], breast cancer [16], and nasopharyngeal carcinoma [17]. This evidence concerns the gene BMI1 and non-small cell lung carcinoma.